On a standalone basis, Indraprastha Medical Corporation net profit surged 132.3% to Rs 15.10 crore on 1.2% fall in net sales to Rs 198.07 crore in Q4 March 2021 over Q4 March 2020.
Profit before tax soared 154.10% to Rs 20.84 crore in Q4 FY21 as against Rs 8.20 crore in Q4 FY20.During the financial year, Indraprastha Medical Corporation's standalone net profit slumped 94.6% to Rs 2.33 crore on 26.17% fall in revenue from operations to Rs 613.38 crore in FY 2021 over FY 2020.
Indraprastha Medical Corporation is engaged in healthcare business.
Shares of Indraprastha Medical Corporation declined 2.79% to Rs 95.95 on BSE. The stock hit an intraday low of Rs 94.80 and an intraday high of Rs 98.50 so far.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU